Robert Schrepfer's most recent trade in ANI Pharmaceuticals Inc was a trade of 5,566 Common Stock done at an average price of $32.7 . Disclosure was reported to the exchange on March 29, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ANI Pharmaceuticals Inc | Robert Schrepfer | SVP - NEW BUS DEV & SPEC SALES | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 29 Mar 2021 | 5,566 | 87,477 (0%) | 0% | 32.7 | 181,897 | Common Stock |